Cancer Research Grants  Advances in Breast Cancer Research
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Huang, J. J.
Right arrow Articles by Kung, H.-f.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Huang, J. J.
Right arrow Articles by Kung, H.-f.
[Cancer Research 62, 3226-3232, June 1, 2002]
© 2002 American Association for Cancer Research


Molecular Biology and Genetics

Ectopic Expression of a COOH-terminal Fragment of the Human Telomerase Reverse Transcriptase Leads to Telomere Dysfunction and Reduction of Growth and Tumorigenicity in HeLa Cells1

Jun Jian Huang2, Marie C. Lin2, Yun Xiu Bai, Da Dao Jing, Benjamin C. Y. Wong, Su Wen Han, Jian Lin, Bing Xu, Cui-fen Huang and Hsiang-fu Kung3

Department Molecular Genetics, Beijing Institute of Biotechnology, Beijing [J. J. H., Y. X. B., S. W. H., J. L., B. X., C-f. H.]; Institute of Molecular Biology and Open Lab of Chemical Biology of The Institute of Molecular Technology for Drug Discovery and Synthesis [J. J. H., M. C. L., H-f. K.]; and Department of Medicine, The University of Hong Kong, Pokfulam Hong Kong [D. D. J., B. C. Y. W.], China

The COOH-terminus of telomerase reverse transcriptase (hTERT) has been shown to participatein the nuclear translocation of TERT. Here, we constructed plasmids expressing the COOH-terminal Mr 27,000 polypeptide of hTERT (hTERTC27) withthe telomerase RNA-binding domains and the reverse transcriptase domains deleted. We showed that ectopic overexpression of this polypeptide caused a defect in telomere maintenance in hTERT-positive HeLa cells, which led to senescence-like growth arrest and apoptosis. The hTERTC27 appears to work by inducing telomere dysfunction, exemplified by significantly increased anaphase chromosome end-to-end fusion events in transfected cells. Significantly, it had no effect on the cellular telomerase enzymatic activity or telomere length. The in vivo effect was further demonstrated as HeLa cells stably expressing hTERTC27 have significantly lower growth rate and reduced tumorigenicity in nude mice xenografts. Results from this study revealed an important function for the COOH terminus of hTERT in maintaining the integrity of telomere structure and chromosome ends, as well as in cell senescence and apoptosis. Furthermore, hTERTC27 provides a new strategy for cancer therapy by inducing telomere dysfunction in cancer cells without affecting the telomerase enzymatic activity.




This article has been cited by other articles:


Home page
J. Cell Sci.Home page
J. Lin, R. Jin, B. Zhang, H. Chen, Y. X. Bai, P. X. Yang, S. W. Han, Y. H. Xie, P. T. Huang, C. Huang, et al.
Nucleolar localization of TERT is unrelated to telomerase function in human cells
J. Cell Sci., July 1, 2008; 121(13): 2169 - 2176.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
S. Huard, T. J. Moriarty, and C. Autexier
The C terminus of the human telomerase reverse transcriptase is a determinant of enzyme processivity
Nucleic Acids Res., July 15, 2003; 31(14): 4059 - 4070.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
B. A. Kosciolek, K. Kalantidis, M. Tabler, and P. T. Rowley
Inhibition of Telomerase Activity in Human Cancer Cells by RNA Interference
Mol. Cancer Ther., March 1, 2003; 2(3): 209 - 216.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2002 by the American Association for Cancer Research.